Pupose: To evaluate the impact of postoperative radiotherapy (PORT) on survival in olfactory neuroblastoma (ONB) patients with different tumor staging.
Material And Methods: Patients with ONB were selected in the Surveillance, Epidemiology and End Results (SEER) database from 2004-2016. Survival analyses were performed using Kaplan-Meier (K-M) method, Cox regression analysis, and competing risk model.
Results: A total of 513 patients were included in the study. Univariate and multivariate analysis results demonstrated that PORT was not an independent prognostic factor for overall survival (OS) of modified Kadish stage A and B patients (P=0.699 and P=0.248, respectively). Kadish stage C and D patients who underwent PORT had significantly better OS than those who did not undergo PORT (P=0.03 and P<0.0001). K-M curves revealed that the 5- and 10-year OS rates of patients who underwent PORT vs. non-PORT were 85.3% vs. 70.4% and 68.2% vs. 56.8% in stage C patients, respectively. For stage D patients, the 5-year OS rates were 70.7% and 42.6%, and 10-year OS rates were 53.4% and 29.5% in the PORT and non-PORT groups, respectively. The competitive risk model revealed that the 5-year cancer-specific cumulative mortality incidence decreased by 26.6% while the 10-year mortality incidence decreased by 41.4% in Kadish stage C patients who were treated using PORT; meanwhile, for Kadish stage D patients who were treated with PORT, the 5- and 10-year mortality incidences were reduced by 35.3% and 42.6%, respectively. Furthermore, we found that chemotherapy was not related to the prognosis of ONB patients (all P>0.05).
Conclusion: Our results indicate that PORT improved survival outcomes of modified Kadish stage C and D ONB patients. However, PORT may not affect survival for modified Kadish stage A and B individuals. Chemotherapy was not recommended for ONB; therefore, further studies are warranted to determine its therapeutic significance.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.canrad.2021.12.006 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Olfactory Neuroblastoma With Divergent Differentiation: Contemporary Management of Unusual Pathology and Literature Review.
Ear Nose Throat J
November 2024
Division of Rhinology, Department of Otolaryngology-Head and Neck Surgery, University of Florida, Gainesville, FL, USA.
Olfactory neuroblastoma (ON; Esthesioneuroblastoma) is a malignant tumor that arises from the olfactory neuroepithelium. Very rarely, ON can histologically display a biphenotypic pattern, with only 7 cases reported in the literature to date. We describe a case of this poorly understood entity and review the patient's histology, pathology, and treatment.
View Article and Find Full Text PDFPathologic dural invasion is associated with regional recurrence in olfactory neuroblastoma: A multi-institutional study.
Int Forum Allergy Rhinol
November 2024
Department of Otolaryngology, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA.
Article Synopsis
- - The study investigates the role of pathological dural invasion (pathDI) as a predictor for neck metastases and recurrence in patients with olfactory neuroblastoma (ONB), using data from a multicenter database of ONB cases collected between 2005 and 2021.
- - Among the 258 patients reviewed, those with pathDI had a significantly lower 10-year neck recurrence-free survival (61.8%) compared to those without it (85.7%), indicating a strong negative impact of pathDI on prognosis.
- - The analysis revealed that pathDI is a significant predictor of neck recurrence and recurrence at other sites, suggesting that future research could lead to changes in treatment strategies for patients with pathDI. *
The value of elective neck irradiation in management of esthesioneuroblastoma: a retrospective study based on propensity score matching.
Radiat Oncol
October 2024
Department of Radiation Oncology, Eye & ENT Hospital of Fudan University, 83 Fenyang Road, Xuhui, Shanghai, 200031, P.R. China.
Article Synopsis
- * Using propensity score matching, the results compared survival outcomes between 96 patients treated with ENI and 53 who were not, revealing significant improvements in overall survival (OS), progression-free survival (PFS), and locoregional relapse-free survival (LRFS) for those receiving ENI.
- * The study concludes that ENI appears to reduce regional failure rates and should be considered in treatment planning for locally advanced node-negative ENB patients, particularly those classified as
[Olfactory neuroblastoma in children: clinical analysis of five cases].
Zhonghua Yi Xue Za Zhi
September 2024
Department of Pediatrics, Beijing Tongren Hospital, Capital Medical University, Beijing 100176, China.
The clinical data of five patients diagnosed with olfactory neuroblastoma (ONB) who were admitted to the Department of Pediatrics, Beijing Tongren Hospital Affiliated to Capital Medical University from January 2012 to January 2024 were retrospectively analyzed. Two males and three females aged 6.2 (5.
View Article and Find Full Text PDFSurvival Analysis and Prognostic Factors After Endonasal Resection of Advanced Olfactory Neuroblastomas: A Single Institution Experience.
J Otolaryngol Head Neck Surg
August 2024
ENT Institute and Department of Otorhinolaryngology, Eye & ENT Hospital, Fudan University, Shanghai, China.
Article Synopsis
- This study examines the prognostic factors affecting patients with advanced olfactory neuroblastoma (ONB) who received endoscopic surgery, analyzing their medical records and outcomes.
- A total of 85 patients were reviewed, with significant findings indicating that certain surgical approaches, like bony skull base resection, may enhance overall survival, while dura resection did not show significant benefits.
- The researchers concluded that combining endoscopic surgery with postoperative radiotherapy is both effective and safe, emphasizing the importance of careful patient selection for dura resection to minimize complications while maximizing survival chances.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!